Skip to main content

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

MSLE holding history

Satellos Bioscience Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MSLE overviewAll 13F holders of MSLEFull Q2 2026 holdings

Shares (Q2 2026)
781
Value
$6.07K
% of portfolio
<0.1%
Quarters held
2
Since Q1 2026
Holdings of MSLE by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026781$6.07K<0.1%+753+2,689.3%AddedHolders
Q1 202628$158<0.1%+28NewHolders